-
-
Most accredited hospitals have been reporting ORYX performance data to The Joint Commission (TJC) on a monthly basis since 2002.
-
Results from an analysis presented at the recent 2011 International AIDS Society conference in Rome suggest that using certain methods of hormonal contraception particularly injectable contraception might double the risk of HIV acquisition in a previously uninfected woman and also might double the risk that an HIV- infected woman will transmit HIV to a previously uninfected male sexual partner.
-
-
Whether chemotherapy is given before or after breast-conserving therapy (BCT) does not have an impact on long-term local-regional outcomes, suggesting treatment success is due more to biologic factors than chemotherapy timing, according to a study1 by researchers at The University of Texas, MD Anderson Cancer Center, Houston, TX.
-
Making written handouts readily available to clinicians interacting with patients is an important element of patient education.
-
Women with a deleterious gene mutation are diagnosed with breast cancer almost eight years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University of Texas MD Anderson Cancer Center, Houston, TX.
-
-
Patients at high risk for a second stroke had a lower risk of stroke and death when treated with aggressive medical therapy than patients who received a brain stent in addition to aggressive medical therapy, according to a nationwide clinical trial that included specialists in Stony Brook University School of Medicine's Departments of Neurology and Neurological Surgery, Stony Brook, NY.
-
In the first 10 months of the Heart Failure Transition Care Program at Tucson, AZ-based Carondelet Health Network, case managers, called nurse partners, prevented hospital readmissions 14 times while managing the care of 62 high-risk patients.